Johnson & Johnson said on Tuesday it had submitted data to the US Food and Drug Administration (FDA) for emergency use authorisation of a booster shot of its Covid-19 vaccine in people aged 18 years and older.

The filing comes after the FDA last week scheduled an Oct 15 meeting of its expert advisory committee to discuss whether to authorise a second shot of J&J's single-dose vaccine.

J&J said its submission includes data from a late-stage study that found...